Outlook Therapeutics OTLK
NASDAQ OTLK
$0.63 +0.00 (+0.74%)
At close: Sep 29, 2026 · 4:00 PM EDT

Outlook Therapeutics (OTLK) EBIT Margin (2015 - 2025)

Updated

Outlook Therapeutics (OTLK) recorded EBIT Margin of -4744.25% in FY2025 (year ended Sep 30, 2025).

Analysis

Outlook Therapeutics (OTLK) EBIT Margin (2015 - 2025) Analysis & Trends

Starting with FY2015, Outlook Therapeutics' EBIT Margin history includes 6 fiscal years.

  • The FY2025 figure is the highest annual EBIT Margin in data going back to FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Outlook Therapeutics 84.78 Mn 49.03 Mn -8,265.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,046.20%
Sep 30, 2019 -216.83%
Jun 30, 2019 -966.72%
Mar 31, 2019 -1,201.86%
Dec 31, 2018 -960.78%
Sep 30, 2018 -1,608.21%
Jun 30, 2018 -935.35%
Mar 31, 2018 -884.97%
Dec 31, 2017 -411.95%
Sep 30, 2017 -100.29%
Jun 30, 2017 -2,420.14%
Mar 31, 2017 -2,585.60%
Dec 31, 2016 -5,870.30%
Sep 30, 2016 -2,011.04%
Jun 30, 2016 -4,450.95%
Mar 31, 2016 -296.91%
Dec 31, 2015 -1,649.75%
Sep 30, 2015 -3,510.23%
Jun 30, 2015 -853.02%
Mar 31, 2015 -2,829.23%
API Access

Outlook Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=OTLK&period=max&api_key=YOUR_API_KEY